Werner Mohl1*, MD, PhD; Timothy D. Henry2, MD; Dejan Milasinovic3, MD; Filomain Nguemo4, PhD; Juergen Hescheler4, MD; Emerson C. Perin5, MD, PhD
1. Department of Cardiac Surgery (Emeritus), Medical University of Vienna, Vienna, Austria; 2. Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA; 3. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; 4. Center
Clinical heart failure prevention and contemporary therapy often involve breaking the vicious cycle of global haemodynamic consequences of myocardial decay. The lack of effective regenerative therapies results in a primary fo